Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, London, United Kingdom; Department of Vascular Surgery, Imperial College Healthcare NHS Trust, London, United Kingdom.
Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, London, United Kingdom; Department of Vascular Surgery, Imperial College Healthcare NHS Trust, London, United Kingdom.
J Vasc Surg. 2020 Jun;71(6):2170-2176. doi: 10.1016/j.jvs.2019.11.012. Epub 2019 Dec 25.
Median arcuate ligament syndrome (MALS) describes the clinical presentation associated with direct compression of the celiac artery by the median arcuate ligament. The poorly understood pathophysiologic mechanism, variable symptom severity, and unpredictable response to treatment make MALS a controversial diagnosis.
This review summarizes the literature pertaining to the pathophysiologic mechanism, presentation, diagnosis, and management of MALS. A suggested diagnostic workup and treatment algorithm are presented.
Individuals with MALS present with signs and symptoms of foregut ischemia, including exercise-induced or postprandial epigastric pain, nausea, vomiting, and weight loss. Consideration of MALS in patients' diagnostic workup is typically delayed. Currently, no group consensus agreement as to the diagnostic criteria for MALS exists; duplex ultrasound, angiography, and gastric exercise tonometry are used in different combinations and with varying diagnostic values throughout the literature. Surgical management involves decompression of the median arcuate ligament's constriction of the celiac artery; robotic, laparoscopic, endoscopic retroperitoneal, and open surgical intervention can provide effective symptom relief, but long-term follow-up data (>5 years) are lacking. Patients treated nonoperatively appear to have worse outcomes.
MALS is an important clinical entity with significant impact on affected individuals. Presenting symptoms, patient demographics, and radiologic signs are generally consistent, as is the short-to medium-term (<5 years) response to surgical intervention. Future prospective studies should directly compare long-term symptomatic and quality of life outcomes after nonoperative management with outcomes after open, laparoscopic, endoscopic retroperitoneal, and robotic celiac artery decompression to enable the development of evidence-based guidelines for the management of MALS.
中位弓状韧带综合征(MALS)描述了与腹主动脉直接受压相关的临床特征,而腹主动脉受压是由中位弓状韧带所致。其发病机制尚不清楚,症状严重程度不同,治疗反应不可预测,这些使得 MALS 的诊断存在争议。
本综述总结了与 MALS 的病理生理机制、表现、诊断和管理相关的文献。提出了一种诊断性检查方法和治疗方案。
患有 MALS 的个体表现出前肠缺血的迹象和症状,包括运动诱发或餐后上腹痛、恶心、呕吐和体重减轻。通常会延迟考虑 MALS 作为患者的诊断性检查。目前,尚无关于 MALS 诊断标准的共识;在文献中,不同组合使用了双功超声、血管造影和胃运动测压,并具有不同的诊断价值。手术治疗涉及中位弓状韧带对腹主动脉的压迫的减压;机器人、腹腔镜、内镜后腹膜和开放式手术干预均可提供有效的症状缓解,但缺乏长期随访数据(>5 年)。非手术治疗的患者似乎预后更差。
MALS 是一种重要的临床实体,对受影响的个体有重大影响。临床表现、患者特征和影像学表现通常一致,手术干预的短期至中期(<5 年)疗效也一致。未来的前瞻性研究应直接比较非手术治疗与开放、腹腔镜、内镜后腹膜和机器人腹主动脉减压后长期症状和生活质量的结果,从而制定 MALS 管理的循证指南。